FUNDING ANNOUNCEMENT SickKids Innovations Take the Stage in the 2025 Proof of Principle Grant Competition The SickKids Industry Partnerships & Commercialization (IP&C) office is excited to announce the winners of the 2025 Proof of Principle (PoP) Grant Competition! Dale Podolsky Streamlining a Novel Minimally Invasive [...]
STRATEGIC INITIATIVE Advancing SickKids Innovations Beyond Proof of Principle with the Technology Advancement Program IP&C’s goal is to support SickKids innovations from discovery to impact, ensuring that promising research advances beyond the lab to make a real difference for patients and communities. Expanding beyond the Proof of Principle (PoP) Grant [...]
FUNDING ANNOUNCEMENT Winners of the 2024 Proof of Principle Grant Competition Christine Bear Senior Scientist, Molecular Medicine Comparison of SickKids CFTR Potentiator to Ensifentrine in Ameliorating COPD in In-Vitro and In-Vivo Models Jayne Danska Senior Scientist, Genetics & Genome Biology [...]
Accelerating Innovation: IP&C's Eighth Annual Proof of Principle Competition Awards $300,000 to Outstanding SickKids' Projects From exploring innovative approaches for epilepsy treatment, to introducing a device that could transform how specimens are collected from the gastrointestinal tract, this year's Proof of Principle (PoP) Grant Competition highlighted [...]
Seventh annual SickKids gap funding competition advances health-care innovations From potential treatments for Clostridium difficile infection and medulloblastoma to a new way to standardize pain behaviour tests, this year’s Proof of Principle (PoP) Grant Competition showcased innovative research advancements at The Hospital for Sick Children (SickKids). Hosted by SickKids [...]
Innovation Showcase returns to highlight SickKids technologies and innovators Summary: Annual commercialization event offers attendees access to emerging therapeutic and diagnostic SickKids technologies with high potential for market disruption and clinical impact. The SickKids Innovation Showcase is returning for its second year, bringing together the latest in cutting-edge [...]
SickKids Ranked One of Canada's Top 40 Research Hospitals for 2021 SickKids has once again been named one of Canada’s top research hospitals by Research Infosource. SickKids ranks first in both researcher intensity and hospital intensity among medium-sized hospitals on the list. For the eleventh consecutive [...]
Pfizer Completes Acquisition of Trillium Therapeutics On November 17, 2021, Pfizer Inc. announced the successful completion of its acquisition of Trillium Therapeutics, a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. This is a great development for Trillium’s foundational technology, based on [...]
SickKids scientist Dr. Jean-Philippe Julien named one of Canada's Top 40 Under 40 Congratulations to Dr. Jean-Philippe Julien, one of our entrepreneurial scientists at The Hospital for Sick Children, on being named a 2021 Honouree of Canada’s Top 40 Under 40! Read the full story on SickKids. [...]
SickKids and U of T spinout PhenoTips raises $2.5 million in seed funding Genetics software start-up PhenoTips, a spinout from The Hospital for Sick Children (SickKids) and University of Toronto (U of T), announced this week that it has raised $2.5 million in a seed funding [...]
General Inquiries
Email: ipc.requests@sickkids.ca
Peter Gilgan Centre for Research and Learning
686 Bay Street, Toronto
Ontario, Canada
M5G 0A4
SickKids Industry Partnerships & Commercialization operates on the traditional land of the Huron-Wendat and Petun First Nations, the Seneca, and the Mississaugas of the Credit River.
© 1999 – 2025 The Hospital for Sick Children (SickKids) – All Rights Reserved.
